Hu Xihao, Qin Yong
Department of Otolaryngology-Head and Neck Surgery，Peking University First Hospital，Beijing，100034，China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Oct;38(10):979-984. doi: 10.13201/j.issn.2096-7993.2024.10.019.
The rise of minimally invasive surgery and the concept of rapid recovery have led to transoral surgery becoming increasingly vital in pharyngolaryngeal surgery. In 2009, the U. S. Food and Drug Administration approved the use of the da Vinci Surgical Robot for transoral robotic surgery（TORS）. Due to its high-definition lens and flexible, precise operation, TORS is rapidly gaining popularity worldwide and expanding its indications. Although some experts in China have attempted to apply TORS to treat pharyngolaryngeal diseases, compared to European and American countries, TORS in China is still in its exploratory stage. This paper briefly reviews the application of TORS in pharyngolaryngeal surgery.
微创手术的兴起以及快速康复理念促使经口手术在咽喉外科手术中变得愈发重要。2009年，美国食品药品监督管理局批准使用达芬奇手术机器人进行经口机器人手术（TORS）。由于其高清镜头以及灵活、精准的操作，TORS在全球范围内迅速受到欢迎并不断拓展其适应证。尽管中国一些专家已尝试应用TORS治疗咽喉疾病，但与欧美国家相比，中国的TORS仍处于探索阶段。本文简要综述了TORS在咽喉外科手术中的应用。
